You are using an outdated browser. Please upgrade your browser to improve your experience.

tirabrutinib hydrochloride

Tirabrutinib is a potent and selective Bruton’s tyrosine kinase (BTK) inhibitor that irreversibly and covalently binds to BTK Cys-481 in B cells and inhibits aberrant B cell receptor signalling in B cell-related cancers and autoimmune diseases.
Target Activities